183 related articles for article (PubMed ID: 32676168)
21. Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer.
Laumont CM; Wouters MCA; Smazynski J; Gierc NS; Chavez EA; Chong LC; Thornton S; Milne K; Webb JR; Steidl C; Nelson BH
Clin Cancer Res; 2021 Jul; 27(14):4089-4100. PubMed ID: 33963000
[TBL] [Abstract][Full Text] [Related]
22. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
Sato E; Olson SH; Ahn J; Bundy B; Nishikawa H; Qian F; Jungbluth AA; Frosina D; Gnjatic S; Ambrosone C; Kepner J; Odunsi T; Ritter G; Lele S; Chen YT; Ohtani H; Old LJ; Odunsi K
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18538-43. PubMed ID: 16344461
[TBL] [Abstract][Full Text] [Related]
23. T cell receptor repertoires of ex vivo-expanded tumor-infiltrating lymphocytes from breast cancer patients.
Park IA; Rajaei H; Kim YA; Lee H; Lee H; Seo JH; Heo SH; Song IH; Gong G; Lee HJ
Immunol Res; 2020 Oct; 68(5):233-245. PubMed ID: 32886262
[TBL] [Abstract][Full Text] [Related]
24. Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response.
Aran A; Lázaro G; Marco V; Molina E; Abancó F; Peg V; Gión M; Garrigós L; Pérez-García J; Cortés J; Martí M
Front Immunol; 2023; 14():1227766. PubMed ID: 37600765
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes of prexasertib monotherapy in recurrent
Lampert EJ; Cimino-Mathews A; Lee JS; Nair J; Lee MJ; Yuno A; An D; Trepel JB; Ruppin E; Lee JM
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32709712
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K
Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361
[TBL] [Abstract][Full Text] [Related]
27. Persistence and enrichment of dominant T cell clonotypes in expanded tumor-infiltrating lymphocytes of breast cancer.
Ham B; Kim SY; Kim YA; Han D; Park T; Cha S; Jung S; Kim JH; Park G; Gong G; Lee HJ; Shin J
Br J Cancer; 2024 May; ():. PubMed ID: 38750113
[TBL] [Abstract][Full Text] [Related]
28. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA
Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470
[TBL] [Abstract][Full Text] [Related]
29. Digital genomic quantification of tumor-infiltrating lymphocytes.
Robins HS; Ericson NG; Guenthoer J; O'Briant KC; Tewari M; Drescher CW; Bielas JH
Sci Transl Med; 2013 Dec; 5(214):214ra169. PubMed ID: 24307693
[TBL] [Abstract][Full Text] [Related]
30. Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer.
Penter L; Dietze K; Ritter J; Lammoglia Cobo MF; Garmshausen J; Aigner F; Bullinger L; Hackstein H; Wienzek-Lischka S; Blankenstein T; Hummel M; Dornmair K; Hansmann L
Oncoimmunology; 2019; 8(6):e1586409. PubMed ID: 31069154
[TBL] [Abstract][Full Text] [Related]
31. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
32. Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing.
Jang M; Yew PY; Hasegawa K; Ikeda Y; Fujiwara K; Fleming GF; Nakamura Y; Park JH
Oncoimmunology; 2015 Nov; 4(11):e1030561. PubMed ID: 26451311
[TBL] [Abstract][Full Text] [Related]
33. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes.
Nakanishi K; Kukita Y; Segawa H; Inoue N; Ohue M; Kato K
Cancer Med; 2016 Sep; 5(9):2513-21. PubMed ID: 27465739
[TBL] [Abstract][Full Text] [Related]
35. Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire.
Sims JS; Grinshpun B; Feng Y; Ung TH; Neira JA; Samanamud JL; Canoll P; Shen Y; Sims PA; Bruce JN
Proc Natl Acad Sci U S A; 2016 Jun; 113(25):E3529-37. PubMed ID: 27261081
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.
Rudqvist NP; Pilones KA; Lhuillier C; Wennerberg E; Sidhom JW; Emerson RO; Robins HS; Schneck J; Formenti SC; Demaria S
Cancer Immunol Res; 2018 Feb; 6(2):139-150. PubMed ID: 29180535
[TBL] [Abstract][Full Text] [Related]
37. TCR Repertoire Diversity of Peripheral PD-1
Han J; Duan J; Bai H; Wang Y; Wan R; Wang X; Chen S; Tian Y; Wang D; Fei K; Yao Z; Wang S; Lu Z; Wang Z; Wang J
Cancer Immunol Res; 2020 Jan; 8(1):146-154. PubMed ID: 31719056
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.
Liu YY; Yang QF; Yang JS; Cao RB; Liang JY; Liu YT; Zeng YL; Chen S; Xia XF; Zhang K; Liu L
Int J Cancer; 2019 Sep; 145(5):1423-1431. PubMed ID: 30664810
[TBL] [Abstract][Full Text] [Related]
39. TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer.
Cui JH; Lin KR; Yuan SH; Jin YB; Chen XP; Su XK; Jiang J; Pan YM; Mao SL; Mao XF; Luo W
Front Immunol; 2018; 9():2729. PubMed ID: 30524447
[TBL] [Abstract][Full Text] [Related]
40. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
